U.S. Markets open in 7 hrs 11 mins

Celldex Therapeutics, Inc. (CLDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.66+0.20 (+8.13%)
At close: 4:00PM EDT
People also watch
Currency in USD

Valuation Measures

Market Cap (intraday) 5341.39M
Enterprise Value 3175.85M
Trailing P/E -2.43
Forward P/E 1-2.77
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)36.10
Price/Book (mrq)1.46
Enterprise Value/Revenue 318.59
Enterprise Value/EBITDA 6-1.53

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profit Margin 0.00%
Operating Margin (ttm)-1,270.87%
Management Effectiveness
Return on Assets (ttm)-24.34%
Return on Equity (ttm)-53.51%
Income Statement
Revenue (ttm)9.46M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)175.70%
Gross Profit (ttm)6.79M
EBITDA -115.22M
Net Income Avi to Common (ttm)-124.73M
Diluted EPS (ttm)-1.09
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)153.98M
Total Cash Per Share (mrq)1.2
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.56
Book Value Per Share (mrq)1.82
Cash Flow Statement
Operating Cash Flow (ttm)-100.35M
Levered Free Cash Flow (ttm)-47.15M

Trading Information

Stock Price History
Beta 2.67
52-Week Change 3-35.26%
S&P500 52-Week Change 316.52%
52 Week High 35.02
52 Week Low 32.20
50-Day Moving Average 32.49
200-Day Moving Average 32.81
Share Statistics
Avg Vol (3 month) 31.22M
Avg Vol (10 day) 31.27M
Shares Outstanding 5128.34M
Float 120.82M
% Held by Insiders 10.67%
% Held by Institutions 159.69%
Shares Short 313.26M
Short Ratio 313.59
Short % of Float 312.61%
Shares Short (prior month) 313.72M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/12
Last Split Date 3Mar 10, 2008